Droplette, founded in 2017 by two MIT-trained engineers, is a pioneering force in the skincare sector, leveraging advanced technology to disrupt traditional methods. With its motto, "Skincare powered by science," the company embodies a commitment to enhancing health and wellness through innovative solutions. Their flagship product, a unique device, employs enhanced aerosol technology to deliver active ingredients beneath the skin's surface, promising more effective treatment than conventional topicals.
Operating within industries like Biotechnology, Health Care, and Wellness Beauty, Droplette combines the expertise of engineers, biologists, dermatologists, and skincare experts. Headquartered in the United States, its approach addresses prevalent skin concerns with a scientific edge.
In a testament to its potential, Droplette secured a $21.05M Series B investment on 03 December 2021 from notable investors, including Amplifyher Ventures, Bolt, Spark Capital, and others. This capital injection underscores investor confidence in the company's transformative vision in skincare technology.